Ticker

Analyst Price Targets — STE

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
October 24, 2024 3:23 amJason BednarPiper Sandler$260.00$221.15StreetInsider Piper Sandler Upgrades STERIS (STE) to Overweight
September 3, 2024 6:28 amBrett FishbinKeyBanc$265.00$241.10TheFly Steris price target raised to $265 from $255 at KeyBanc
May 10, 2024 8:20 amJason BednarPiper Sandler$225.00$225.95StreetInsider STERIS (STE) PT Raised to $225 at Piper Sandler
April 4, 2024 4:23 amMike PolarkWolfe Research$245.00$216.65StreetInsider STERIS (STE) PT Raised to $245 at Wolfe Research

Latest News for STE

STERIS plc $STE Shares Bought by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. increased its position in STERIS plc (NYSE: STE) by 688.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,712 shares of the medical equipment provider's stock after purchasing an additional 39,043 shares during the period. Dana Investment Advisors Inc.'s holdings

Defense World • Feb 24, 2026
STERIS plc (NYSE:STE) Receives Consensus Rating of “Moderate Buy” from Analysts

STERIS plc (NYSE: STE - Get Free Report) has received an average rating of "Moderate Buy" from the eight brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokerages

Defense World • Feb 22, 2026
STERIS plc (NYSE:STE) Sees Large Growth in Short Interest

STERIS plc (NYSE: STE - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 1,560,494 shares, an increase of 22.7% from the January 15th total of 1,271,747 shares. Currently, 1.6% of the company's stock are sold short. Based

Defense World • Feb 17, 2026
Contrasting QHSLab (OTCMKTS:USAQ) & STERIS (NYSE:STE)

STERIS (NYSE: STE - Get Free Report) and QHSLab (OTCMKTS:USAQ - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Valuation and Earnings This table compares STERIS and QHSLab"s gross

Defense World • Feb 10, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

Senate Trading Disclosures

NameTransaction DateTypeAssetAmountLink

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top